Sohela Shah, PhD

Title(s)Prog Mgr InVent/Catalyst Fund, Innovation Ventures
SchoolChancellor/EVC/FAS
AddressSFGH Bldg 40
Phone--
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Tufts Graduate School of Biomedical Sciences, Boston, MAPh.D2006Genetics
    Rutgers University, New Brunswick, NJBS2000Biochemistry

    Collapse Overview 
    Collapse Overview
    Sohela is a program manager at the Catalyst Program and InVent Fund teams at Innovation Ventures at UCSF, where she supports UCSF faculty in advancing their research projects towards technology patenting and commercialization in order to bring cutting-edge innovations out of the lab and into the world. Prior to joining Innovation Ventures, she worked on a startup project at The Production Board, a technology incubator and investment holding company in San Francisco, as the founding product manager.

    Sohela earned her Ph.D. in Genetics from Tufts University- School of Biomedical Sciences in Boston and did postdoctoral training in rare disease genetics at the University of California San Francisco. After her postdoc, she joined Memorial Sloan Kettering Cancer Center as a Niehaus Scholar to continue her research in clinical genetics and genomics. Following her research fellowship in New York, she led the development of NGS data interpretation and reporting software for genetic test results at Ingenuity Systems (acquired by QIAGEN) and Invitae Corp.
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Leveraging network analytics to infer patient syndrome and identify causal genes in rare disease cases. BMC Genomics. 2017 08 11; 18(Suppl 5):551. Krämer A, Shah S, Rebres RA, Tang S, Richards DR. PMID: 28812537; PMCID: PMC5558185.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    2. Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges. Hum Mutat. 2017 09; 38(9):1182-1192. Daneshjou R, Wang Y, Bromberg Y, Bovo S, Martelli PL, Babbi G, Lena PD, Casadio R, Edwards M, Gifford D, Jones DT, Sundaram L, Bhat RR, Li X, Pal LR, Kundu K, Yin Y, Moult J, Jiang Y, Pejaver V, Pagel KA, Li B, Mooney SD, Radivojac P, Shah S, Carraro M, Gasparini A, Leonardi E, Giollo M, Ferrari C, Tosatto SCE, Bachar E, Azaria JR, Ofran Y, Unger R, Niroula A, Vihinen M, Chang B, Wang MH, Franke A, Petersen BS, Pirooznia M, Zandi P, McCombie R, Potash JB, Altman RB, Klein TE, Hoskins RA, Repo S, Brenner SE, Morgan AA. PMID: 28634997; PMCID: PMC5600620.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    3. Lessons from the CAGI-4 Hopkins clinical panel challenge. Hum Mutat. 2017 09; 38(9):1155-1168. Chandonia JM, Adhikari A, Carraro M, Chhibber A, Cutting GR, Fu Y, Gasparini A, Jones DT, Kramer A, Kundu K, Lam HYK, Leonardi E, Moult J, Pal LR, Searls DB, Shah S, Sunyaev S, Tosatto SCE, Yin Y, Buckley BA. PMID: 28397312; PMCID: PMC5600166.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    4. Evaluating the association of multiple single nucleotide polymorphisms with response to gemcitabine and platinum combination chemotherapy in urothelial carcinoma of the bladder
. Int J Clin Pharmacol Ther. 2017 Mar; 55(3):203-209. Alanee SR, Shah S, Zabor EC, Vijai J, Ostrovnaya I, Garcia-Grossman IR, Pendse DV, Littman J, Regazzi AM, Offit K, Bajorin DF. PMID: 28177276.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    5. Better bioinformatics will help labs manage genetic testing. MLO Med Lab Obs. 2017 02; 49(2):28, 31. Shah S. PMID: 30005479.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Intrahepatic Cholestasis of Pregnancy (ICP) in U.S. Latinas and Chileans: Clinical features, Ancestry Analysis, and Admixture Mapping. PLoS One. 2015; 10(6):e0131211. Bull LN, Hu D, Shah S, Temple L, Silva K, Huntsman S, Melgar J, Geiser MT, Sanford U, Ortiz JA, Lee RH, Kusanovic JP, Ziv E, Vargas JE. PMID: 26126184; PMCID: PMC4488338.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    7. Genome Sequencing of Multiple Primary Tumors Reveals a Novel PALB2 Variant. J Clin Oncol. 2016 Mar 10; 34(8):e61-7. Schrader KA, Stratton KL, Murali R, Laitman Y, Cavallone L, Offit L, Wen YH, Thomas T, Shah S, Rau-Murthy R, Manschreck C, Salo-Mullen E, Otegbeye E, Corines M, Zhang L, Norton L, Hudis C, Klein RJ, Kauff ND, Robson M, Stadler ZK, Haber DA, Lipkin SM, Friedman E, Foulkes WD, Altshuler D, Vijai J, Offit K. PMID: 24982446.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    8. Prevalence of HOXB13 mutation in a population of Ashkenazi Jewish men treated for prostate cancer. Fam Cancer. 2013 Dec; 12(4):597-600. Alanee S, Shah S, Vijai J, Schrader K, Hamilton R, Rau-Murthy R, Sarrel K, Manschreck C, Eastham J, Offit K. PMID: 23475555; PMCID: PMC5073797.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    9. CCBE1 mutation in two siblings, one manifesting lymphedema-cholestasis syndrome, and the other, fetal hydrops. PLoS One. 2013; 8(9):e75770. Shah S, Conlin LK, Gomez L, Aagenaes Ø, Eiklid K, Knisely AS, Mennuti MT, Matthews RP, Spinner NB, Bull LN. PMID: 24086631; PMCID: PMC3784396.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    10. A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia. Nat Genet. 2013 Oct; 45(10):1226-1231. Shah S, Schrader KA, Waanders E, Timms AE, Vijai J, Miething C, Wechsler J, Yang J, Hayes J, Klein RJ, Zhang J, Wei L, Wu G, Rusch M, Nagahawatte P, Ma J, Chen SC, Song G, Cheng J, Meyers P, Bhojwani D, Jhanwar S, Maslak P, Fleisher M, Littman J, Offit L, Rau-Murthy R, Fleischut MH, Corines M, Murali R, Gao X, Manschreck C, Kitzing T, Murty VV, Raimondi S, Kuiper RP, Simons A, Schiffman JD, Onel K, Plon SE, Wheeler D, Ritter D, Ziegler DS, Tucker K, Sutton R, Chenevix-Trench G, Li J, Huntsman DG, Hansford S, Senz J, Walsh T, Lee M, Hahn CN, Roberts K, King MC, Lo SM, Levine RL, Viale A, Socci ND, Nathanson KL, Scott HS, Daly M, Lipkin SM, Lowe SW, Downing JR, Altshuler D, Sandlund JT, Horwitz MS, Mullighan CG, Offit K. PMID: 24013638; PMCID: PMC3919799.
      View in: PubMed   Mentions: 127     Fields:    Translation:Humans
    11. Assessment of SLX4 Mutations in Hereditary Breast Cancers. PLoS One. 2013; 8(6):e66961. Shah S, Kim Y, Ostrovnaya I, Murali R, Schrader KA, Lach FP, Sarrel K, Rau-Murthy R, Hansen N, Zhang L, Kirchhoff T, Stadler Z, Robson M, Vijai J, Offit K, Smogorzewska A. PMID: 23840564; PMCID: PMC3694110.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    12. Absence of loss of heterozygosity of BRCA1 in a renal tumor from a BRCA1 germline mutation carrier. Fam Cancer. 2013 Mar; 12(1):125-7. Alanee S, Shah S, Murali R, Rau-Murthy R, Schrader KA, Offit K. PMID: 23086583; PMCID: PMC5073794.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Rare variants in XRCC2 as breast cancer susceptibility alleles. J Med Genet. 2012 Oct; 49(10):618-20. Hilbers FS, Wijnen JT, Hoogerbrugge N, Oosterwijk JC, Collee MJ, Peterlongo P, Radice P, Manoukian S, Feroce I, Capra F, Couch FJ, Wang X, Guidugli L, Offit K, Shah S, Campbell IG, Thompson ER, James PA, Trainer AH, Gracia J, Benitez J, van Asperen CJ, Devilee P. PMID: 23054243.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    14. Rare de novo germline copy-number variation in testicular cancer. Am J Hum Genet. 2012 Aug 10; 91(2):379-83. Stadler ZK, Esposito D, Shah S, Vijai J, Yamrom B, Levy D, Lee YH, Kendall J, Leotta A, Ronemus M, Hansen N, Sarrel K, Rau-Murthy R, Schrader K, Kauff N, Klein RJ, Lipkin SM, Murali R, Robson M, Sheinfeld J, Feldman D, Bosl G, Norton L, Wigler M, Offit K. PMID: 22863192; PMCID: PMC3415553.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    15. Strain background modifies phenotypes in the ATP8B1-deficient mouse. PLoS One. 2010 Feb 01; 5(2):e8984. Shah S, Sanford UR, Vargas JC, Xu H, Groen A, Paulusma CC, Grenert JP, Pawlikowska L, Sen S, Elferink RP, Bull LN. PMID: 20126555; PMCID: PMC2813882.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimals
    16. Babesia microti primarily invades mature erythrocytes in mice. Infect Immun. 2006 Jun; 74(6):3204-12. Borggraefe I, Yuan J, Telford SR, Menon S, Hunter R, Shah S, Spielman A, Gelfand JA, Wortis HH, Vannier E. PMID: 16714547; PMCID: PMC1479280.
      View in: PubMed   Mentions: 13     Fields:    Translation:AnimalsCells
    Sohela's Networks
    Concepts (129)
    Derived automatically from this person's publications.
    _
    Co-Authors (8)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _